380 related articles for article (PubMed ID: 8550737)
1. Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth.
Huber M; Poulin R
J Clin Endocrinol Metab; 1996 Jan; 81(1):113-23. PubMed ID: 8550737
[TBL] [Abstract][Full Text] [Related]
2. Polyamine involvement in basal and estradiol-stimulated insulin-like growth factor I secretion and action in breast cancer cells in culture.
Glikman PL; Manni A; Bartholomew M; Demers L
J Steroid Biochem Mol Biol; 1990 Sep; 37(1):1-10. PubMed ID: 2242341
[TBL] [Abstract][Full Text] [Related]
3. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.
Thomas T; Thomas TJ
Breast Cancer Res Treat; 1994 Feb; 29(2):189-201. PubMed ID: 8012036
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effect of spermine depletion by N-cyclohexyl-1,3-diaminopropane in human breast cancer cells.
Huber M; Poulin R
Cancer Res; 1995 Feb; 55(4):934-43. PubMed ID: 7850811
[TBL] [Abstract][Full Text] [Related]
5. The estrogen-occupied estrogen receptor functions as a negative regulator to inhibit cell proliferation induced by insulin/IGF-1: a cell context-specific antimitogenic action of estradiol on rat lactotrophs in culture.
Kawashima K; Yamakawa K; Takahashi W; Takizawa S; Yin P; Sugiyama N; Kanba S; Arita J
Endocrinology; 2002 Jul; 143(7):2750-8. PubMed ID: 12072410
[TBL] [Abstract][Full Text] [Related]
6. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
[TBL] [Abstract][Full Text] [Related]
7. Interactions between growth factor secretion and polyamines in MCF-7 breast cancer cells.
Cohen FJ; Manni A; Glikman P; Bartholomew M; Demers L
Eur J Cancer; 1990; 26(5):603-8. PubMed ID: 2144749
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.
Kremmer T; Pälyi I; Daubner D; Boldizsár M; Vincze B; Paulik E; Sugár J; Pokorny E; Túry E
Anticancer Res; 1991; 11(5):1807-13. PubMed ID: 1768053
[TBL] [Abstract][Full Text] [Related]
9. Role of polyamines in estradiol-induced growth of human breast cancer cells.
Lima G; Shiu RP
Cancer Res; 1985 Jun; 45(6):2466-70. PubMed ID: 3921243
[TBL] [Abstract][Full Text] [Related]
10. Polyamine involvement in the growth of hormone-responsive and -resistant human breast cancer cells in culture.
Glikman P; Manni A; Demers L; Bartholomew M
Cancer Res; 1989 Mar; 49(6):1371-6. PubMed ID: 2493979
[TBL] [Abstract][Full Text] [Related]
11. Polyamine involvement in the secretion and action of TGF-alpha in hormone sensitive human breast cancer cells in culture.
Kim I; Manni A; Lynch J; Demers L
Breast Cancer Res Treat; 1991 May; 18(2):83-91. PubMed ID: 1912611
[TBL] [Abstract][Full Text] [Related]
12. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of polyamine synthesis and growth by difluoromethylornithine plus methylthioadenosine in methylthioadenosine phosphorylase-deficient murine lymphoma cells.
Yamanaka H; Kubota M; Carson DA
Cancer Res; 1987 Apr; 47(7):1771-4. PubMed ID: 3102048
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells.
Thomas T; Thomas TJ
Cancer Res; 1994 Feb; 54(4):1077-84. PubMed ID: 8313364
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the polyamine pathway in antiestrogen-induced growth inhibition of human breast cancer.
Cohen FJ; Manni A; Glikman P; Bartholomew M; Demers L
Cancer Res; 1988 Dec; 48(23):6819-25. PubMed ID: 3180091
[TBL] [Abstract][Full Text] [Related]
17. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.
Hamelers IH; van Schaik RF; van Teeffelen HA; Sussenbach JS; Steenbergh PH
Exp Cell Res; 2002 Feb; 273(1):107-17. PubMed ID: 11795951
[TBL] [Abstract][Full Text] [Related]
18. Post-translational cooperativity of ornithine decarboxylase induction by estrogens and peptide growth factors in human breast cancer cells.
Huber M; Poulin R
Mol Cell Endocrinol; 1996 Mar; 117(2):211-8. PubMed ID: 8737382
[TBL] [Abstract][Full Text] [Related]
19. Role of polyamines in the growth of hormone-responsive and -resistant human breast cancer cells in nude mice.
Manni A; Badger B; Martel J; Demers L
Cancer Lett; 1992 Sep; 66(1):1-9. PubMed ID: 1451091
[TBL] [Abstract][Full Text] [Related]
20. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
